Change of neutrophil count after treatment of intravenous immunoglobulin in children with idiopathic thrombocytopenic purpura |
Park, Jun Young
(Department of Pediatrics, Pusan National University College of Medicine)
Park, Ji Ae (Department of Pediatrics, Pusan National University College of Medicine) Park, Seong Shik (Department of Pediatrics, Pusan National University College of Medicine) Lim, Young Tak (Department of Pediatrics, Pusan National University College of Medicine) |
1 | Lightsey AL, Koenig HM, McMillan R, Stone JR. Platelet-associated immunoglobulin G in childhood idiopathic thrombocytopenic purpura. J Pediatr 1979;94:201-4 DOI |
2 | Imbach P, Barandun S, d'Apuzzo V, Baumgartner C, Hirt A, Morell A, et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981;1:1228-31 |
3 | Ryan ME, Webster ML, Statler JD. Adverse effects of intravenous immunoglobulin therapy. Clin Pediatr(Phila) 1996;35:23-31 DOI ScienceOn |
4 | Niebanck AE, Kwiatkowski JL, Raffini LJ. Neutropenia following IVIG therapy in pediatric patients with immunemediated thrombocytopenia. J Pediatr Hematol Oncol 2005;27:145-7 DOI ScienceOn |
5 | Berkman SA, Lee ML, Gale RP. Clinical uses of intravenous immunoglobulins. Ann Intern Med 1990;112:278-92 DOI ScienceOn |
6 | Lassiter HA, Bibb KW, Bertolone SJ, Patel CC, Stroncek DF. Neonatal immune neutropenia following the administration of intravenous immune globulin. Am J Pediatr Hematol Oncol 1993;15:120-3 DOI ScienceOn |
7 | Sugita K, Eguchi M. Suppressive effect of intravenous immunoglobulin on peripheral blood neutrophil count in patients with idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 2005;27:7-10 DOI ScienceOn |
8 | NIH consensus conference. Intravenous immunoglobulin. Prevention and treatment of disease. JAMA 1990;264:3189-93 DOI |
9 | Schulman I. Diagnosis and treatment: management of idiopathic thrombocytopenic purpura. Pediatrics 1964;33:979-80 |
10 | Simmons SM, Main CA, Yaish HM, Rutzky J. Idiopathic thrombocytopenic purpura in child. J Pediatr 1975;87:16-22 DOI |
11 | Berkovitch M, Dolinski G, Tauber T, Aladjem M, Kaplinsky C. Neutropenia as a complication of intravenous immunoglobulin (IVIG) therapy in children with immune thrombocytopenic purpura: common and non-alarming. Int J Immunopharmacol 1999;21:411-5 DOI ScienceOn |
12 | Duhem C, Dicato MA, Ries F. Side-effects of intravenous immune globulins. Clin Exp Immunol 1994;97(Suppl 1):79-83 |
13 | Altznauer F, von Gunten S, Spath P, Simon HU. Concurrent presence of agonistic and antagonistic anti-CD95 autoantibodies in intravenous Ig preparations. J Allergy Clin Immunol 2003;112:1185-90 DOI ScienceOn |
14 | Lusher JM, Zuelzer WW. Idiopathic thrombocytopenic purpura in child. J Pediatr 1966;68:971-9 DOI |
15 | Tsujimoto H, Takeshita S, Nakatani K, Kawamura Y, Tokutomi T, Sekine I. Intravenous immunoglobulin therapy induces neutrophil apoin kawasaki disease. Clin Immunol 2002;103:161-8 DOI ScienceOn |
16 | Walker RW, Walker W. Idiopathic thrombocytopenia, initial illness and long term follow up. Arch Dis Child 1984;59:316-22 DOI ScienceOn |
17 | Tam DA, Morton LD, Stroncek DF, Leshner RT. Neutropenia in a patient receiving intravenous immune globulin. J Neuroimmunol 1996;64:175-8 DOI ScienceOn |
18 | McElfresh AE. Idiopathic thrombocytopenic purpura--to treat or not to treat? J Pediatr 1975;87:160-1 DOI |
19 | Veys PA, Macey MG, Owens CM, Newland AC. Neutropenia following intravenous immunoglobulin. Br Med J 1988;296:1800 |
20 | Clarkson SB, Bussel JB, Kimberly RP, Valinsky JE, Nachman RL, Unkeless JC. Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody. N Engl J Med 1986;314:1236-9 DOI ScienceOn |